首页 › 膀胱癌 › 宾夕法尼亚州 › Pittsburgh
Pittsburgh PA 膀胱癌临床试验
7项针对 膀胱癌的研究正在 Pittsburgh及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
招募中2 期
- UPMC-Magee Womens Hospital, Pittsburgh
- UPMC-Saint Margaret, Pittsburgh
- UPMC Hillman Cancer Center, Pittsburgh
- 以及另外 7 项
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
招募中2 期
- UPMC Hillman Cancer Center, Pittsburgh
- UPMC-Passavant Hospital, Pittsburgh
- UPMC-Saint Clair Hospital Cancer Center, Pittsburgh
- 以及另外 2 项
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
招募中3 期
- AHN Allegheny General Hospital, Pittsburgh
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
招募中2 期
- University of Pittsburgh Medical Center, Pittsburgh
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
招募中1 期
- Allegheny General Hospital, Pittsburgh
- University of Pittsburgh Medical Center, Pittsburgh
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
招募中观察性研究
- Allegheny Health Network, Pittsburgh
Virtual Histology of the Bladder Wall for Bladder Cancer Staging
招募中早期 I 期
- UPMC Hillman Cancer Center - Dept of Urology, Pittsburgh
其他城市的 膀胱癌试验
- New York City, NY35 项研究
- Nashville, TN31 项研究
- Houston, TX31 项研究
- Dallas, TX27 项研究
- Boston, MA26 项研究
- Washington, DC26 项研究
- Los Angeles, CA24 项研究
- Baltimore, MD24 项研究
- St. Louis, MO22 项研究
- Philadelphia, PA21 项研究
- Seattle, WA21 项研究
- Edison, NJ21 项研究
Pittsburgh的其他研究
- 非小细胞肺癌48 项研究
- 癌症（所有类型）41 项研究
- 乳腺癌39 项研究
- 结直肠癌32 项研究
- 转移性癌症31 项研究
- 黑色素瘤31 项研究
- 卵巢癌30 项研究
- 子宫内膜癌23 项研究
- 肺癌23 项研究
- 前列腺癌23 项研究
- 卒中22 项研究
- 头颈鳞状细胞癌22 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月5日。每项研究自行设定入选标准，由研究团队决定谁能参与。